Bipolar disorder is a chronic mental health condition characterized by dramatic shifts in mood, energy, and activity levels — cycling between periods of extremely elevated or irritable mood (manic or hypomanic episodes) and periods of profound sadness or hopelessness (depressive episodes). An estimated 2.8% of U.S. adults — approximately 7 million people — experience bipolar disorder in any given year, with prevalence nearly equal between males (2.9%) and females (2.8%). (NIMH)

Globally, 37 million people live with bipolar disorder — including approximately 3.8 million adolescents aged 10–19. (WHO, 2025) Bipolar disorder is one of the leading causes of disability worldwide, and on average, people with the condition die 13 years earlier than the general population — a gap driven by physical health complications, suicide risk, and limited access to care. (WHO, 2025) With appropriate treatment, people with bipolar disorder can manage their symptoms and live meaningful, productive lives.

Key Takeaways

• Prevalence: 2.8% of U.S. adults are affected annually; 2.9% of adolescents aged 13–18 meet lifetime diagnostic criteria, with 2.6% experiencing severe impairment. (NIMH)
• Lifelong condition: Bipolar disorder usually requires lifelong treatment — but an effective plan combining medication, psychotherapy, and lifestyle management can enable stable, functional living. (NIMH)
• Suicide risk: People with bipolar disorder face elevated suicide risk — including during manic states — making early diagnosis, ongoing monitoring, and crisis planning essential components of care. (NAMI)
• Co-occurring disorders: Bipolar disorder significantly increases the risk of developing anxiety disorders and substance use disorders — and many people with bipolar disorder are misdiagnosed or untreated, often for years. (WHO, 2025)
• Misdiagnosis is common: Because people typically seek help during depressive episodes, bipolar disorder is frequently mistaken for unipolar depression — delaying appropriate treatment and worsening outcomes. (NAMI)
• Treatment works: Mood stabilizers, antipsychotics, and psychosocial interventions including CBT, psychoeducation, and family-focused therapy are proven effective for both acute episodes and long-term relapse prevention. (WHO, 2025)
• Physical health impact: People with bipolar disorder are more likely to smoke, misuse alcohol, and develop cardiovascular or respiratory disease — reinforcing the need for whole-person, integrated care. (WHO, 2025)

What Is Bipolar Disorder?

Bipolar disorder — formerly called manic-depressive illness — is a chronic brain disorder that causes clear shifts in mood, energy, activity levels, and concentration. The NIMH describes these shifts as more severe than normal emotional ups and downs — episodes that are distinct in duration, intensity, and the degree to which they disrupt everyday functioning. (NIMH)

A person with bipolar disorder alternates between two main episode types. Manic or hypomanic episodes involve an extremely elevated, expansive, or irritable mood with increased energy, decreased need for sleep, and behavior that often leads to serious consequences. Depressive episodes involve persistent sadness, low energy, loss of interest in activities, and in severe cases, thoughts of death or suicide. WHO notes that people with bipolar disorder are at increased risk of suicide and of developing co-occurring anxiety and substance use disorders. (WHO, 2025)

The condition primarily affects working-age adults, but it also occurs in youth. Symptoms interfere with relationships, employment, and the ability to carry out daily responsibilities — making bipolar disorder one of the leading causes of disability globally. The DSM-5 organizes bipolar disorder into distinct subtypes based on the type, severity, and duration of mood episodes experienced. (NAMI)

Types of Bipolar Disorder

The DSM-5 defines four main bipolar disorder classifications, each differentiated by the pattern, severity, and duration of mood episodes.

Type	Defining Feature	Episode Duration Threshold	Hospitalization Risk
Bipolar I	At least one full manic episode; depressive episodes common but not required for diagnosis	Mania: ≥ 7 days (or any duration if hospitalization required)	High — severe mania frequently requires inpatient care
Bipolar II	At least one hypomanic episode and one major depressive episode; no full manic episodes	Hypomania: ≥ 4 consecutive days; Depression: ≥ 2 weeks	Lower than Bipolar I — but depressive episodes cause significant disability
Cyclothymic Disorder	Chronic mood instability with hypomanic and depressive symptoms that don’t meet full episode criteria	Symptoms present for ≥ 2 years in adults; ≥ 1 year in children/adolescents	Low — but carries risk of progression to Bipolar I or II
Other Specified / Unspecified	Bipolar-like symptoms that don’t fit the above categories but cause significant distress or impairment	Varies by presentation	Varies

Bipolar I Disorder

Bipolar I disorder is defined by the presence of at least one manic episode lasting a minimum of seven days — or any duration if the symptoms are so severe that immediate hospitalization is required. Depressive episodes typically occur and last at least two weeks, but they are not required for diagnosis. The manic episodes of Bipolar I produce the most severe impairment of all bipolar subtypes — causing marked dysfunction at work, in relationships, and in personal safety. NAMI notes that during manic states, people are often unaware of the negative consequences of their behavior. (NAMI)

Bipolar II Disorder

Bipolar II disorder involves at least one hypomanic episode and at least one major depressive episode, with no history of full mania. Hypomania is a less severe form of mania that does not cause the extreme impairment or require hospitalization — and many people with Bipolar II find hypomanic periods appealing because they feel productive and energized. This is one reason the condition is frequently misdiagnosed: people commonly seek care during depressive episodes and do not report hypomanic symptoms as problems. (NAMI) WHO confirms that many people with bipolar disorder are misdiagnosed or untreated — and face widespread stigma and discrimination that further delays appropriate care. (WHO, 2025)

Cyclothymic Disorder

Cyclothymic disorder is a chronic pattern of mood instability involving numerous periods of hypomanic and depressive symptoms over at least two years in adults. The symptoms do not meet full clinical criteria for a hypomanic or major depressive episode, but the persistent cycling causes significant distress and functional impairment. NIMH acknowledges cyclothymia as a bipolar spectrum condition with meaningful overlap with Bipolar I and II in terms of symptoms and treatment approach. (NIMH)

Symptoms of Bipolar Disorder

Bipolar disorder symptoms fall into two main episode categories — manic/hypomanic and depressive — each with distinct features, durations, and functional impacts. Some individuals also experience mixed features, where symptoms of mania and depression occur simultaneously. (NIMH)

Manic Episode Symptoms

A manic episode is defined by an abnormally elevated, expansive, or irritable mood and increased energy or activity — present most of the day, nearly every day, for at least one week. DSM-5 diagnostic criteria require at least three of the following symptoms (four if mood is only irritable):

• Inflated self-esteem or grandiosity — believing one has special powers, connections, or importance
• Decreased need for sleep — feeling rested after only 2–3 hours
• More talkative than usual; pressured speech that is difficult to interrupt
• Flight of ideas or racing thoughts that jump rapidly between topics
• Distractibility — attention pulled easily by irrelevant stimuli
• Increased goal-directed activity or psychomotor agitation
• Excessive involvement in high-risk activities — reckless spending, hypersexuality, impulsive business decisions — with a high potential for serious harm (NIMH)

NAMI emphasizes that although some people find the elevated mood of mania appealing — especially after a depressive period — the high does not stop at a comfortable or controllable level. Moods rapidly become more irritable, judgment becomes severely impaired, and behavior grows increasingly unpredictable. (NAMI)

Depressive Episode Symptoms

A major depressive episode in bipolar disorder requires at least five of the following nine symptoms for at least two weeks, representing a change from previous functioning. At least one symptom must be either depressed mood or loss of interest:

• Depressed mood most of the day, nearly every day (feeling sad, empty, or hopeless)
• Markedly diminished interest or pleasure in all, or almost all, activities
• Significant unintentional weight loss or gain, or changes in appetite
• Insomnia or hypersomnia nearly every day
• Psychomotor agitation or retardation observable by others
• Fatigue or loss of energy nearly every day
• Feelings of worthlessness, or excessive or inappropriate guilt
• Difficulty concentrating, thinking clearly, or making decisions
• Recurrent thoughts of death, suicidal ideation, or a specific suicide plan or attempt (NIMH)

NAMI notes that bipolar depression is often more difficult to treat than unipolar depression and may require a customized treatment plan. Suicide is an ever-present danger in bipolar disorder — including during manic states — making continuous safety monitoring critical. (NAMI) If you or someone you know is in crisis, call or text 988 (Suicide & Crisis Lifeline) immediately.

Hypomanic Episode Symptoms

Hypomanic episodes involve the same symptom profile as full mania but at a lower intensity. They last at least four consecutive days, do not cause marked impairment, and do not require hospitalization or involve psychosis. Many people with Bipolar II disorder experience hypomania as a period of heightened productivity and elevated mood — which is precisely why it often goes unreported to clinicians. (WHO, 2025) Despite being less severe than mania, hypomanic episodes are still clinically significant and mark a clear change from the person’s usual behavior.

What Causes Bipolar Disorder?

Scientists have not yet identified a single cause of bipolar disorder. Current evidence points to a combination of biological, genetic, psychological, and social factors that interact to influence onset, trajectory, and outcomes. (WHO, 2025)

Factor	What the Evidence Shows
Genetics	Family history significantly increases risk. If a parent or sibling has bipolar disorder, the likelihood of developing it is notably higher — though having a family history does not guarantee the condition will develop. Even in identical twins, if one twin has bipolar disorder, the other may not develop it. (NAMI)
Brain structure and chemistry	Research suggests differences in brain structure and function — including neurotransmitter systems governing mood regulation — contribute to the disorder. NIMH funds ongoing research into the biological, genetic, and environmental factors that influence when and how symptoms appear. (NIMH)
Stress and life events	Stressful events — including bereavement, illness, difficult relationships, divorce, and financial problems — can trigger a manic or depressive episode in susceptible individuals. (NAMI)
Sleep disruption	Irregular sleep is one of the most consistently identified triggers for mood episodes. WHO identifies lifestyle factors including regular sleep as essential protective elements in bipolar management. (WHO, 2025)
Substance use	Alcohol, stimulants, and other substances can trigger or worsen mood episodes and complicate diagnosis. People with bipolar disorder are more likely to use alcohol — and co-occurring substance use disorder worsens overall prognosis. (WHO, 2025; SAMHSA)

How Is Bipolar Disorder Diagnosed?

Bipolar disorder must be diagnosed by a licensed mental health professional with training in differential diagnosis — not through self-assessment or a single visit. NAMI stresses that before any psychiatric diagnosis is made, a comprehensive evaluation of physical and mental health is essential. (NAMI) Diagnosis typically involves a detailed clinical interview covering mood episode history, family psychiatric history, current functioning, and a review of any co-occurring conditions.

One of the most clinically significant challenges in diagnosing bipolar disorder is that most people first present during a depressive episode. Because they do not typically identify prior hypomanic periods as problematic, many are initially diagnosed with unipolar major depression — and treated with antidepressants alone, which can destabilize mood in people with bipolar disorder. WHO confirms that many people with bipolar disorder worldwide are misdiagnosed or untreated, with stigma and discrimination further limiting access to accurate diagnosis and care. (WHO, 2025)

An accurate diagnosis requires ruling out other conditions that can produce similar symptoms, including:

• Unipolar major depressive disorder
• Attention-deficit/hyperactivity disorder (ADHD) — particularly in children and adolescents
• Borderline personality disorder
• Substance-induced mood disorder
• Medical conditions affecting mood (thyroid dysfunction, neurological disorders)

NIMH notes that children diagnosed with bipolar disorder may also have ADHD, early-onset psychosis, PTSD, learning disabilities, or substance use issues — making comprehensive evaluation especially important in this population. (NAMI)

Bipolar Disorder and Co-Occurring Conditions

Bipolar disorder rarely occurs in isolation. NIMH actively researches the relationship between bipolar disorder and co-occurring conditions — particularly anxiety disorders and substance use disorders — because understanding these connections is key to more effective treatment. (NIMH) Some people with bipolar disorder also experience symptoms of psychosis, such as hallucinations or delusions, during severe episodes.

• Substance use disorder: People with bipolar disorder are significantly more likely to misuse alcohol and other substances. SAMHSA’s clinical advisory confirms that bipolar disorder and substance use disorder frequently co-occur, creating complex treatment challenges. Substance use can trigger mood episodes, worsen symptoms, and interfere with medication effectiveness — requiring integrated treatment that addresses both conditions simultaneously. (SAMHSA)
• Anxiety disorders: WHO identifies anxiety as one of the most common co-occurring conditions in bipolar disorder. (WHO, 2025) Anxiety symptoms are present across all phases of the illness — not only during depressive episodes.
• Physical health conditions: People with bipolar disorder are more likely to develop cardiovascular and respiratory diseases, and to smoke. WHO highlights the importance of monitoring and managing comorbid physical health conditions as part of comprehensive bipolar care. (WHO, 2025)
• ADHD (in children): Symptom overlap between bipolar disorder and ADHD — including distractibility and impulsivity — makes differential diagnosis in children particularly challenging. NIMH research emphasizes that youth diagnoses must be made carefully, with a full mental and physical health evaluation. (NIMH)

NIMH advises that co-occurring mental health and substance use disorders require integrated care — combining mental health treatment and substance use treatment in a coordinated plan — rather than treating each condition separately. (NIMH)

Treatment and Management of Bipolar Disorder

Bipolar disorder requires lifelong treatment — but with the right combination of medication, therapy, and self-management strategies, most people can control their symptoms and maintain a high quality of life. NAMI is clear: if left untreated, the symptoms of bipolar disorder get worse. (NAMI) Treatment is most effective when initiated early and sustained consistently, even during periods of stability.

Treatment Type	How It Works	Primary Use
Mood Stabilizers (Lithium, Valproate)	Lithium is a first-line treatment for acute mania and long-term relapse prevention; evidence suggests it also reduces suicide risk. Valproate and carbamazepine are effective for acute mania and complex subtypes including rapid cycling. (NAMI)	Acute mania; long-term maintenance; relapse prevention
Antipsychotics	Used alongside mood stabilizers to manage acute manic episodes; some second-generation antipsychotics are also approved for bipolar depression. (WHO, 2025)	Acute mania; mixed features; psychotic symptoms
Anticonvulsants (Lamotrigine)	Lamotrigine is used to delay recurrence of Bipolar I episodes, particularly depressive recurrence. Other anticonvulsants (valproate, carbamazepine) treat mania and are preferred for rapid cycling presentations. (NAMI)	Depressive episode prevention; rapid cycling; maintenance
Cognitive Behavioral Therapy (CBT)	Identifies and changes negative thought patterns and behaviors associated with depression; teaches coping strategies and early warning sign recognition. (NAMI)	Depressive episodes; relapse prevention; coping skills
Psychoeducation	Teaches people with bipolar disorder and their families about the illness, its triggers, and how to adhere to a treatment plan — proven to reduce relapse rates and improve medication adherence. (WHO, 2025)	Relapse prevention; treatment adherence; self-management
Family-Focused Therapy	Involves family members in treatment to improve communication, reduce expressed emotion, and build a supportive recovery environment at home. (NAMI)	Family communication; reducing relapse triggers; adolescent treatment
Lifestyle Management	Regular sleep, physical activity, a healthy diet, reduced stress, and consistent mood monitoring. WHO identifies these as essential components of managing bipolar disorder that complement but do not replace medication. (WHO, 2025)	Maintenance; sleep regulation; episode prevention

WHO is clear that medications — primarily mood stabilizers and antipsychotics — are essential for treatment, but are usually insufficient to achieve full recovery on their own. Psychological interventions including CBT, interpersonal therapy, and psychoeducation effectively reduce depressive symptoms and the likelihood of recurrence when combined with pharmacotherapy. Adults with bipolar disorder who achieve full remission typically need to continue mood stabilizers or antipsychotics for at least six months; those with multiple episodes usually require longer-term maintenance treatment. (WHO, 2025)

For people with co-occurring substance use disorder, SAMHSA recommends integrated treatment that addresses both bipolar disorder and substance use within a coordinated care plan — since treating either condition in isolation worsens outcomes for both. (SAMHSA)

Frequently Asked Questions About Bipolar Disorder

How is bipolar disorder different from normal mood swings?

Normal mood fluctuations are part of everyday life — brief, proportionate to circumstances, and do not significantly disrupt functioning. Bipolar disorder is fundamentally different in duration, intensity, and consequence. Manic episodes last at least 7 days (or any length if hospitalization is needed), produce measurable impairment in work, relationships, or personal safety, and involve behaviors — like reckless spending, hypersexuality, or sleep abandonment — that cause serious harm. Depressive episodes last at least two weeks and can be so debilitating that basic daily functioning becomes impossible. NIMH describes these shifts as more severe than the normal ups and downs experienced by everyone. (NIMH) The clinical threshold is impairment — not frequency or intensity alone.

Is bipolar disorder hereditary?

Genetics plays a significant role in bipolar disorder, but inheritance is not deterministic. Having a parent or sibling with bipolar disorder increases the likelihood of developing the condition — but the role of genetics is not absolute. NAMI cites studies of identical twins showing that even if one twin develops bipolar disorder, the other may not — demonstrating that genes create vulnerability, not certainty. (NAMI) WHO confirms that multiple factors — biological, psychological, social, and structural — interact to influence onset and trajectory. (WHO, 2025) A family history is an important piece of clinical context, but it is not a diagnosis.

Does bipolar disorder increase suicide risk?

Yes — bipolar disorder significantly elevates suicide risk. WHO identifies suicide as one of the leading risks associated with bipolar disorder. (WHO, 2025) NAMI emphasizes that suicide is an ever-present danger in bipolar disorder — including during manic states, not only during depressive episodes. (NAMI) Learning to recognize the behavioral warning signs of manic and depressive episodes — and developing a crisis safety plan with a treatment provider — are essential protective steps. NAMI also notes evidence that lithium can lower suicide risk, though the FDA has not formally approved it for this specific purpose. If you or someone you know is experiencing suicidal thoughts, call or text 988 immediately.

Can bipolar disorder co-occur with substance use disorder?

Yes — and this combination is clinically common. WHO confirms that people with bipolar disorder are more likely to misuse alcohol and have a physical health condition. (WHO, 2025) SAMHSA has dedicated a clinical advisory specifically to bipolar disorder and co-occurring substance use disorders, recognizing the complex interaction between mood episodes and substance misuse — where each condition worsens the other and complicates treatment. (SAMHSA) NIMH supports integrated care as the evidence-based approach for people with co-occurring substance use and mental disorders — addressing both conditions simultaneously within one coordinated treatment plan. (NIMH)

What medications are used to treat bipolar disorder?

The primary medication classes for bipolar disorder are mood stabilizers, antipsychotics, and anticonvulsants. Lithium — the oldest and most studied mood stabilizer — is a first-line treatment for acute mania and long-term maintenance, with evidence suggesting it also reduces suicide risk. (NAMI) Valproate and carbamazepine are effective for acute mania and better suited for complex presentations like rapid cycling. Lamotrigine is used to delay depressive recurrence in Bipolar I. Antipsychotics are used for acute mania and episodes with psychotic features. WHO notes that medications may cause side effects including sedation, involuntary muscle movements, and metabolic changes — all of which should be monitored and managed to support adherence. (WHO, 2025) Medication choice depends on the bipolar subtype, episode polarity, and individual patient factors.

Can bipolar disorder be managed long-term?

Yes. WHO is unambiguous: even though symptoms often recur, recovery is possible. With appropriate care — which typically combines medication, psychological interventions, and lifestyle adjustments — people with bipolar disorder can cope with their symptoms and live meaningful, productive lives. (WHO, 2025) NAMI confirms that proper treatment helps most people control their mood swings and other symptoms — and that long-term management requires a sustained commitment to treatment, even during periods when symptoms appear stable. (NAMI) Self-management strategies — including mood tracking, regular sleep, stress reduction, and recognizing early warning signs of episodes — are evidence-supported components of long-term stability.

How is bipolar disorder treated in children and adolescents?

NIMH data shows an estimated 2.9% of U.S. adolescents aged 13–18 have a lifetime bipolar disorder diagnosis, with 2.6% experiencing severe impairment. (NIMH) Treatment approaches for children and adolescents are similar to those for adults, with medication as the first line of treatment — but children respond to medications differently, and some may require more than one type due to the complexity of their symptoms. NAMI notes that before any psychiatric diagnosis, children must receive a comprehensive evaluation of both physical and mental health, including assessment for co-occurring conditions like ADHD, PTSD, and learning disabilities. (NAMI) Psychotherapy — including CBT and family-focused therapy — is also an important component of pediatric bipolar care.

Summary: Bipolar disorder is a chronic, lifelong condition affecting 2.8% of U.S. adults annually, characterized by alternating manic, hypomanic, and depressive episodes that impair functioning and elevate suicide risk — but which respond well to evidence-based treatment combining mood stabilizers, psychotherapy, psychoeducation, and integrated care for co-occurring conditions.

If you or someone close to you is living with bipolar disorder — especially alongside a co-occurring substance use disorder or trauma history — integrated, person-centered care makes a measurable difference. Worthy Wellness Center in Carlsbad, California provides evidence-based mental health and dual-diagnosis treatment across a full continuum of care, including PHP, IOP, outpatient therapy, and holistic interventions tailored to complex mood disorders.